Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cataract SurgeryPayerPolicy · IBX-COMMERCIAL-11-01-07 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cast and Splint Applications and Associated SuppliesPayerPolicy · IBX-COMMERCIAL-00-10-15 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Casgevy (exagamglogene autotemcel)PayerPolicy · IBX-COMMERCIAL-08-02-14 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Carfilzomib (Kyprolis)PayerPolicy · IBX-COMMERCIAL-08-01-05 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Care Management and Care Planning ServicesPayerPolicy · IBX-COMMERCIAL-00-01-59 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) ProgramsPayerPolicy · IBX-COMMERCIAL-10-01-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Canakinumab (Ilaris)PayerPolicy · IBX-COMMERCIAL-08-01-51 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Burosumab-twza (Crysvita)PayerPolicy · IBX-COMMERCIAL-08-01-49 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bundled Procedure CodesPayerPolicy · IBX-COMMERCIAL-00-01-52AB-EA8079987D | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bronchial ValvesPayerPolicy · IBX-COMMERCIAL-11-16-09 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Brentuximab Vedotin (Adcetris)PayerPolicy · IBX-COMMERCIAL-08-01-13 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Breast PumpsPayerPolicy · IBX-COMMERCIAL-05-00-76 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Brachytherapy and Accelerated Whole Breast Irradiation using Three-Dimensional Conformation Radiation Therapy (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-09-00-10AA-75477E1E28 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Botulinum Toxin AgentsPayerPolicy · IBX-COMMERCIAL-08-00-26AF-4AD42BB08F | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bone Mineral Density (BMD) TestingPayerPolicy · IBX-COMMERCIAL-09-00-04 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing AidsPayerPolicy · IBX-COMMERCIAL-11-01-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Blinatumomab (Blincyto)PayerPolicy · IBX-COMMERCIAL-08-01-21 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bioimpedance for the Detection of LymphedemaPayerPolicy · IBX-COMMERCIAL-07-06-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Biofeedback TherapyPayerPolicy · IBX-COMMERCIAL-07-00-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Billing Requirements for Multiple Births for Professional ProvidersPayerPolicy · IBX-COMMERCIAL-00-10-38 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located Within a Facility or on a Facility CampusPayerPolicy · IBX-COMMERCIAL-00-10-39 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bevacizumab (Avastin) and Related Biosimilars For Oncologic UsePayerPolicy · IBX-COMMERCIAL-08-00-66 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Betibeglogene Autotemcel [Beti-Cel (ZYNTEGLO)]PayerPolicy · IBX-COMMERCIAL-08-01-89 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Beremagene Geperpavec (Vyjuvek)PayerPolicy · IBX-COMMERCIAL-08-02-10 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Belimumab (Benlysta) for Intravenous UsePayerPolicy · IBX-COMMERCIAL-08-00-99 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Belantamab mafodotin-blmf (Blenrep)PayerPolicy · IBX-COMMERCIAL-08-02-53 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Bariatric SurgeryPayerPolicy · IBX-COMMERCIAL-11-03-02 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute RhinosinusitisPayerPolicy · IBX-COMMERCIAL-11-16-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Axatilimab-csfr (Niktimvo) for Intravenous UsePayerPolicy · IBX-COMMERCIAL-08-02-34 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Avelumab (Bavencio)PayerPolicy · IBX-COMMERCIAL-08-01-64 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Autonomic Nervous System TestingPayerPolicy · IBX-COMMERCIAL-07-03-23 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)PayerPolicy · IBX-COMMERCIAL-05-00-29 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Autologous Chondrocyte Implantation (ACI) and Other Cell-based Treatments of Focal Articular Cartilage Lesions (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-11-14-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Auricular ProsthesesPayerPolicy · IBX-COMMERCIAL-05-00-82 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Atidarsagene autotemcel (Lenmeldy)PayerPolicy · IBX-COMMERCIAL-08-02-24 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)PayerPolicy · IBX-COMMERCIAL-08-01-69 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Assisted Reproductive Technology for Infertility and Oocyte CryopreservationPayerPolicy · IBX-COMMERCIAL-07-10-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-06-02-27 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze)PayerPolicy · IBX-COMMERCIAL-08-01-35 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Artificial Intervertebral Cervical Disc Insertion (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-11-14-19 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Aqueous Shunts, Minimally Invasive Glaucoma Surgeries (including Microstents), Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaPayerPolicy · IBX-COMMERCIAL-11-05-16 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Applied Behavior Analysis (ABA) for the Treatment of Autism Spectrum Disorder (ASD)PayerPolicy · IBX-COMMERCIAL-14-00-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Application and Removal of TattoosPayerPolicy · IBX-COMMERCIAL-11-08-05 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Apos biomechanical shoe systemPayerPolicy · IBX-COMMERCIAL-05-00-84 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Apheresis TherapyPayerPolicy · IBX-COMMERCIAL-06-03-04 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ankle-Foot/Knee-Ankle-Foot OrthosisPayerPolicy · IBX-COMMERCIAL-05-00-39 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Anifrolumab-fnia (Saphnelo)PayerPolicy · IBX-COMMERCIAL-08-01-82 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint ManagementPayerPolicy · IBX-COMMERCIAL-01-00-12 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Amivantamab-vmjw (Rybrevant) and Amivantamab and hyaluronidase-lpuj (Rybrevant Faspro)PayerPolicy · IBX-COMMERCIAL-08-01-90 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) MonitoringPayerPolicy · IBX-COMMERCIAL-07-02-21 | New policy |
|---|